Davis Polk advised Roivant Sciences Ltd. in the offering. Roivant Sciences Ltd. announced its at-the-market offering program under which Roivant may issue and sell its common shares...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented IDEAYA, while Davis Polk advised the representatives of the several underwriters in the offering. IDEAYA Biosciences, Inc. (Nasdaq: IDYA) announced the pricing of an...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Jefferies, the sales agent, in the offering. Immunocore Holdings plc announced the SEC-registered at-the-marketing offering program of its American depositary shares (ADSs) representing its ordinary...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Novo Nordisk on the deal while Goodwin Procter represented Forma Therapeutics. Novo Nordisk announced its approximately $1.1 billion acquisition of Forma Therapeutics. Under the...
You must be a Standard 1 Year member to access this content.
Davis Polk advised SVB Securities LLC, the sole initial purchaser, in the offering. Assertio Holdings, Inc. executed the offering of $70 million aggregate principal amount of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers in the offering. Oak Street Health, Inc. announced the $180.3 million secondary offering of 7,000,000 million shares of common stock...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Terns Pharmaceuticals in the offering, while Davis Polk & Wardwell represented the underwriters. Terns Pharmaceuticals, Inc. (Nasdaq: TERN) has agreed to sell, by...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Bloom Energy in the transaction, while Davis Polk advised the underwriters. Bloom Energy Corporation (NYSE: BE), the developer of a solid-oxide platform for...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Barclays Capital, the manager, in the offering. Arrival executed a SEC-registered at-the-market offering of its ordinary shares for up to an aggregate offering price of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agent Jefferies in the offering. Vaccitech plc executed an at-the-marketing offering program of its American depositary shares representing its ordinary shares under...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised TransMedics, while Davis Polk advised representatives of the underwriters in the offering. TransMedics Group, Inc. executed its $150 million SEC-registered follow-on offering of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised TruArc Partners on the deal, while Dentons Cohen & Grigsby advised Molded Devices. TruArc Partners, LP announced its acquisition of Molded Devices, Inc....
You must be a Standard 1 Year member to access this content.
